134 related articles for article (PubMed ID: 5319620)
21. [Experiences with the parenteral use of the bronchosecretolytic bromhexine].
Grundner H; Hoflehner G
Wien Med Wochenschr; 1970 Jul; 120(30):535-6. PubMed ID: 5523385
[No Abstract] [Full Text] [Related]
22. [Experience in treating patients with chronic pneumonia by inhalation of mucolytic agents].
Komarov FI; Daniliak IG; Guliaeva FE
Sov Med; 1977 Apr; (4):87-9. PubMed ID: 877720
[No Abstract] [Full Text] [Related]
23. [Respiratory mechanism studies with Bisolvon].
Günthner W
Ther Umsch; 1965 Jul; 22(7):387-8. PubMed ID: 5319622
[No Abstract] [Full Text] [Related]
24. [Clinical and clinical-chemical experiences with a dexamethasone ester applied by inhalation].
Schmidt G; Weist FR
Med Monatsschr; 1969 Jan; 23(1):30-4. PubMed ID: 5766685
[No Abstract] [Full Text] [Related]
25. [Inhalation therapy].
None LV; Lemarié E; Diot P
Rev Infirm; 2006 Feb; (118):16-23. PubMed ID: 16562547
[No Abstract] [Full Text] [Related]
26. [Rehabilitation of respiratory tract diseases].
Sill V
MMW Munch Med Wochenschr; 1983 Feb; 125(6):111-2. PubMed ID: 6405230
[No Abstract] [Full Text] [Related]
27. [Guidelines of the German Respiratory League. Mucolytic drugs now also have a place in therapy of COPD].
MMW Fortschr Med; 2002 Sep; 144(38):60. PubMed ID: 12395714
[No Abstract] [Full Text] [Related]
28. [Parenteral treatment of respiratory tract diseases with Bisolvone].
Stahlmann W; Siehoff F; Mathey HG; Schilling T; Weis H
Dtsch Med J; 1966 Aug; 17(16):478-80. PubMed ID: 5925468
[No Abstract] [Full Text] [Related]
29. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
30. [Clinical study of the properties of Bisolvon in the therapy of respiratory diseases in children].
Vendemmia S; Maurino G; Goglia R; Della Peruta A
Minerva Pediatr; 1981 Mar; 33(5):227-31. PubMed ID: 7242493
[No Abstract] [Full Text] [Related]
31. Studies with steam generated aerosols; the clinical application of antispasmodics, mucolytics, antibiotics and other agents in a variety of sino-respiratory diseases.
PRIGAL SJ
Ann Otol Rhinol Laryngol; 1952 Mar; 61(1):206-41. PubMed ID: 14915412
[No Abstract] [Full Text] [Related]
32. [Clinical experimental studies on the pharmacodynamic effect of alupent in a double blind test with simultaneous bisolvon therapy].
Seith U
Med Welt; 1966 Sep; 37():1982-4. PubMed ID: 5341649
[No Abstract] [Full Text] [Related]
33. [Aerosol therapy in acute respiratory diseases (review of the literature)].
Finogeev IuP
Voen Med Zh; 1981 Apr; (4):43-5. PubMed ID: 7018070
[No Abstract] [Full Text] [Related]
34. [Cyto-diagnostic test results following sputum provocation with Bisolvon].
Fischnaller M; Schwarzenberg E; Wrbka E
Wien Klin Wochenschr; 1967 Jan; 79(1):1-3. PubMed ID: 5340279
[No Abstract] [Full Text] [Related]
35. [The ZIN-4 individual inhalator for phytoncides].
Gerasimov AL
Med Prom SSSR; 1966 Mar; 20(3):51-3. PubMed ID: 5985071
[No Abstract] [Full Text] [Related]
36. [Inhalation therapy using catecholamines].
Thiede D; Ulmer WT
Med Klin; 1971 May; 66(19):705-9. PubMed ID: 5573824
[No Abstract] [Full Text] [Related]
37. Theory and practice of the use of expectorants reviewed from clinical aspects.
Nagy G
Ther Hung; 1984; 32(1):6-12. PubMed ID: 6400475
[No Abstract] [Full Text] [Related]
38. [The effect of repeated inhalation of 4% Mistabron on the ultrastructure of respiratory tract epithelium].
Konrádová V; Vávrová V; Janota J
Cesk Pediatr; 1979 Oct; 34(10):586-9. PubMed ID: 509649
[No Abstract] [Full Text] [Related]
39. [Practical trials with Bisolvon, a new bronchial expectorant].
Kleine-Allekotte B
Hippokrates; 1965 Jul; 36(13):521-3. PubMed ID: 5319471
[No Abstract] [Full Text] [Related]
40. [Bisolvon, a predominantly secrolytic and secromotor expectorant].
Adelmann G
Med Monatsschr; 1965 Jul; 19(7):325-7. PubMed ID: 5320480
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
